Poseida Therapeutics Stock Current Valuation
Valuation analysis of Poseida Therapeutics helps investors to measure Poseida Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Poseida Therapeutics Company Current Valuation Analysis
Poseida Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Poseida Therapeutics Current Valuation | 777.81 M |
Most of Poseida Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poseida Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Poseida Therapeutics has a Current Valuation of 777.81 M. This is 94.58% lower than that of the Biotechnology sector and 83.26% lower than that of the Health Care industry. The current valuation for all United States stocks is 95.32% higher than that of the company.
Poseida Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poseida Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics of similar companies.Poseida Therapeutics is currently under evaluation in current valuation category among its peers.
Poseida Fundamentals
| Return On Equity | -0.58 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.40) % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 777.81 M | |||
| Shares Outstanding | 97.47 M | |||
| Shares Owned By Insiders | 27.64 % | |||
| Shares Owned By Institutions | 58.44 % | |||
| Number Of Shares Shorted | 3.59 M | |||
| Price To Earning | 214.00 X | |||
| Price To Book | 10.62 X | |||
| Price To Sales | 6.14 X | |||
| Revenue | 64.7 M | |||
| Gross Profit | (21.57 M) | |||
| EBITDA | (109.04 M) | |||
| Net Income | (123.43 M) | |||
| Cash And Equivalents | 142.56 M | |||
| Cash Per Share | 1.66 X | |||
| Total Debt | 85.42 M | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 3.69 X | |||
| Book Value Per Share | 0.90 X | |||
| Cash Flow From Operations | (92.17 M) | |||
| Short Ratio | 1.49 X | |||
| Earnings Per Share | (0.63) X | |||
| Price To Earnings To Growth | (0.63) X | |||
| Target Price | 9.5 | |||
| Number Of Employees | 350 | |||
| Beta | 0.54 | |||
| Market Capitalization | 925.93 M | |||
| Total Asset | 273.88 M | |||
| Retained Earnings | (594.29 M) | |||
| Working Capital | 155.16 M | |||
| Current Asset | 10.59 M | |||
| Current Liabilities | 5.1 M | |||
| Net Asset | 273.88 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |